A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05101486. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate non-inferiority in terms of humoral immune responses of Ad26.RSV.preF-based study vaccine lots representative of different aged vaccine in comparison to a non-aged Ad26.RSV.preF-based study vaccine lot.
Study identification
- NCT ID
- NCT05101486
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 755 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2021 (Actual)
- Primary completion
- Mar 28, 2022 (Actual)
- Completion
- Sep 20, 2022 (Actual)
- Last update posted
- May 25, 2025
2021 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Alabama Research Center, LLC | Athens | Alabama | 35611 | — |
| Achieve Clinical Research, LLC | Vestavia Hills | Alabama | 35216 | — |
| Hope Research Institute | Phoenix | Arizona | 85023 | — |
| Clinical Research Consulting | Milford | Connecticut | 06460 | — |
| Accel Research Sites | DeLand | Florida | 32720 | — |
| Pharmax Research Clinic Inc | Miami | Florida | 33126 | — |
| Suncoast Research Group | Miami | Florida | 33135 | — |
| Suncoast Research Associates, LLC | Miami | Florida | 33173 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| Centennial Medical Group | Elkridge | Maryland | 21075 | — |
| Be Well Clinical Studies | Lincoln | Nebraska | 68516 | — |
| American Health Network, LLC | Charlotte | North Carolina | 28277 | — |
| CTI Clinical Trial and Consulting Services | Cincinnati | Ohio | 45212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05101486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 25, 2025 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.